|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Celularity (NASDAQ: CELU) through any online brokerage.
The latest price target for Celularity (NASDAQ: CELU) was reported by Morgan Stanley on November 24, 2021. The analyst firm set a price target for 9.00 expecting CELU to rise to within 12 months (a possible 34.33% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Celularity (NASDAQ: CELU) is $6.7 last updated Mon Nov 29 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Celularity.
Celularity’s $Q4 earnings are confirmed for after-market on February 10, 2022.
There is no upcoming split for Celularity.
Celularity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.